HCPCS J3357
Ustekinumab, for subcutaneous injection, 1 mg (CMS descriptor)
Drugs Drug code Work RVU per service none (2022 fee schedule; adds 0 work RVUs)
Trend
Medicare payment on the code
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2022.
Billers
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2022.
| observed | calculated | calculated | calculated | calculated | calculated | reported | |
|---|---|---|---|---|---|---|---|
| 2022 | 15 | $3,345,351 | -86% | 25,470 | 1,305 | 3,987 | 0.00 |
| 2021 | 57 | $24,352,963 | – (Not compared: 2021 changed office visit values) | 174,709 | 2,205 | 6,750 | 0.00 |
| 2020 | 66 | $34,194,686 | first year in data | 230,896 | 2,138 | 11,419 | 0.00 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2022.
By state
No state has a reportable line for J3357 in 2022.
Top metro areas
No metro area has a reportable line for J3357 in 2022.
Specialties billing J3357 nationally
Not listed: 4 specialties with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2022.
Top billers of J3357 nationally
Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.
Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations